Emerging Therapies for Recurrent Pericarditis: Interleukin‐1 inhibitors

Recurrent pericarditis (RP) is a complex inflammatory disorder associated with adverse outcomes and poor quality of life. After the first episode of acute pericarditis, a non‐negligible group of patients will fail to achieve complete remission despite treatment and will be challenged by side effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo Presti, Saberio, Elajami, Tarec K., Reyaldeen, Reza, Anthony, Chris, Imazio, Massimo, Klein, Allan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Contemporary Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649126/
https://www.ncbi.nlm.nih.gov/pubmed/34569270
http://dx.doi.org/10.1161/JAHA.121.021685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649126/
https://www.ncbi.nlm.nih.gov/pubmed/34569270
http://dx.doi.org/10.1161/JAHA.121.021685

Ejemplares similares